No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents / therapeutic use*
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / pathology*
-
Female
-
Humans
-
Neoplasm Recurrence, Local
-
Neoplasm Staging
-
Prognosis
-
Receptor, ErbB-2 / metabolism*
-
Trastuzumab
-
Tumor Burden
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
Trastuzumab